Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)

Supplier: -ABYNTEK-
Reference: ABK1-P8187
Name: Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)
Category: Protein
Research Area: Tumor immunity;
Aditional Names: MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors
Unit: 10ug/50ug/100ug/200ug/1mg
Format: Freeze-dried powder
Host: E.coli
Reactivity: Homo sapiens (Human)
Application: Positive Control; Immunogen; SDS-PAGE; WB.
Expression system: Prokaryotic expression